Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Silver

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Medical and Pediatric Oncology|January 1, 1984
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patientsM S Brower, M Coleman, M W Pasmantier, et al.
Leukemia & Lymphoma|May 1, 1992
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytarabine and lomustine. A Cancer and Leukemia Group B studyR T Silver, A Karanas, K B Dear, et al.
The American Journal of Medicine|March 1, 1978
Morbidity of staging laparotomy in Hodgkin's diseaseS Brogadir, M A Fialk, M Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.
Leukemia|December 15, 2007
JAK2 Mutations are present in all cases of polycythemia veraY L Wang, K Vandris, A Jones, et al.
Seminars in Hematology|April 1, 1987
Advances in chemotherapy for large cell lymphomaM Coleman, G Gerstein, A Topilow, et al.
Cancer Research|May 1, 1973
Evaluation of aniline mustard in patients with multiple myelomaR A Kyle, G Costa, M R Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1983
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B studyM Green, C Horton, M Spaulding, et al.
Leukemia|July 1, 1995
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group BK R Rai, F Davey, B Peterson, et al.
Cancer Treatment Reports|December 1, 1977
Piperazinedione in metastatic renal carcinomaM W Pasmantier, M Coleman, B J Kennedy, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Medical and Pediatric Oncology|January 1, 1984
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patientsM S Brower, M Coleman, M W Pasmantier, et al.
Leukemia & Lymphoma|May 1, 1992
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytarabine and lomustine. A Cancer and Leukemia Group B studyR T Silver, A Karanas, K B Dear, et al.
The American Journal of Medicine|March 1, 1978
Morbidity of staging laparotomy in Hodgkin's diseaseS Brogadir, M A Fialk, M Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.
Leukemia|December 15, 2007
JAK2 Mutations are present in all cases of polycythemia veraY L Wang, K Vandris, A Jones, et al.
Seminars in Hematology|April 1, 1987
Advances in chemotherapy for large cell lymphomaM Coleman, G Gerstein, A Topilow, et al.
Cancer Research|May 1, 1973
Evaluation of aniline mustard in patients with multiple myelomaR A Kyle, G Costa, M R Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1983
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B studyM Green, C Horton, M Spaulding, et al.
Leukemia|July 1, 1995
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group BK R Rai, F Davey, B Peterson, et al.
Cancer Treatment Reports|December 1, 1977
Piperazinedione in metastatic renal carcinomaM W Pasmantier, M Coleman, B J Kennedy, et al.
Pageof 14